Search Options Stock News and Analysis from Schaeffer's

Bullish Trendline Has Never Failed Crispr Therapeutics Stock

https://www.schaeffersresearch.com/content/analysis/2024/04/17/bullish-trendline-has-never-failed-crispr-therapeutics-stock

4/17/2024 12:58 PM

Crispr Therapeutics AG (NASDAQ:CRSP) is 2.8% lower at $56.35 this afternoon, continuing a pullback from a Feb. 22, more than two-year high of $91.10. Over the last month, CRSP has erased 20.8% and now...

Crispr Therapeutics Stock Sinks Despite FDA Approval

https://www.schaeffersresearch.com/content/options/2023/12/11/crispr-therapeutics-stock-sinks-despite-fda-approval

12/11/2023 3:31 PM

Crispr Therapeutics AG ( NASDAQ:CRSP) stock is down 7.2% to trade at $59.89 at last check, despite its gene therapy treatment for sickle cell disease in partnership with Vertex (VRTX) last week receiv...

3 Stocks Making Outsized Moves Today

https://www.schaeffersresearch.com/content/news/2023/04/13/3-stocks-making-outsized-moves-today

4/13/2023 2:59 PM

Stocks are bouncing in the wake of the latest encouraging inflation reading. Three names making notable moves include Delta Air Lines Inc (NYSE:DAL), biotech stock Crispr Therapeutics AG (NASDAQ:CRSP...

3 Biotech Stocks to Watch Heading Into 2023

https://www.schaeffersresearch.com/content/options/2022/12/29/3-biotech-stocks-to-watch-heading-into-2023

12/29/2022 2:49 PM

Pharma and biotech stocks are enjoying tailwinds as part of the broad market rally today. Biogen Inc (NASDAQ:BIIB), Crispr Therapeutics AG (NASDAQ:CRSP), and also Vertex Pharmaceuticals Incorporated ...

Biotech Stock Could Be Headed Toward New Record Highs

https://www.schaeffersresearch.com/content/analysis/2020/10/13/biotech-stock-could-be-headed-toward-new-record-highs

10/13/2020 3:34 PM

The shares of Crispr Therapeutics (NASDAQ:CRSP) are up 0.8% to trade at $100.24 at last check. And while the pharmaceutical stock has cooled off from its all-time-high of $105.12 on Aug. 19, it has s...

PEOPLE ALSO SEARCH FOR